Turing pharmaceuticals CEO, Martin Shkreli, has announced that he will dramatically reduce his planned price hike for Daraprim, though he did not reveal the new cost
Turing Pharmaceuticals will dramatically reduce its planned price hike to Daraprim, Shkreli told NBC News on Tuesday night. This was declared two days after the story hit the pages of the New York Times. Outrage, outrage, outrage, that’s what the Americans felt since the time he raised the price of ...
Also read: Clinton decries fake news 'epidemic'